跳至主要内容
临床试验/NCT02286934
NCT02286934已完成1 期

A Clinical Trial to Investigate the Influence of Cytochrome P450 2D6 Polymorphism on the Pharmacokinetic/Pharmacodynamics Characteristics of Carvedilol in Healthy Korean Volunteers

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2014年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
24
试验地点
1
主要终点
AUC (area under the plasma concentration-time curve) of carvedilol

研究概览

简要总结

A Clinical Study to Evaluate the Effect of Cytochrome P450 2D6 polymorphism on Pharmacokinetics/Pharmacodynamics After Multiple Administration of Carvedilol

详细描述

This study has an open-label, one-sequence, multiple drug administration design. The purpose of this study is as follows;

To evaluate the change of the result of Isoproterenol Sensitivity Test according to Cytochrome P450 2D6 genotype after the multiple administration of carvedilol

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy Subjects aged 20 - 45 years
  • A body mass index (BMI) in the range 18.0 kg/m2 (inclusive) - 27.0 kg/m2 (inclusive).
  • Sufficient ability to understand the nature of the study and any hazards of participating in it. Provide written informed consent after being fully. informed about the study procedures.

排除标准

  • Presence or history of hypersensitivity or allergic reactions to drugs including investigational product (Carvedilol, Isoproterenol).
  • Subject judged not eligible for study participation by investigator.

研究组 & 干预措施

Carvedilol

Experimental
  • Day 1 to 3 : Carvedilol 12.5 mg qd
  • Day 4 to 8 : Carvedilol 25 mg qd
  • Day 9 to 11 : Carvedilol 12.5 mg qd

Isoproterenol Sensitivity Test

  • Day 0, 1.5h post-dose Injection of isoproterenol 4 times (0.25, 0.5, 1, 2 ug/mL), time interval of 10 minutes.
  • Day 1, 8, 1.5h post-dose Injection of isoproterenol 4 times (5, 10, 20, 40 ug/mL), time interval of 10 minutes.

Measure change of heart rates after 1, 2, 3 minutes post injection of isoproterenol.

干预措施: Carvedilol (Drug)

Carvedilol

Experimental
  • Day 1 to 3 : Carvedilol 12.5 mg qd
  • Day 4 to 8 : Carvedilol 25 mg qd
  • Day 9 to 11 : Carvedilol 12.5 mg qd

Isoproterenol Sensitivity Test

  • Day 0, 1.5h post-dose Injection of isoproterenol 4 times (0.25, 0.5, 1, 2 ug/mL), time interval of 10 minutes.
  • Day 1, 8, 1.5h post-dose Injection of isoproterenol 4 times (5, 10, 20, 40 ug/mL), time interval of 10 minutes.

Measure change of heart rates after 1, 2, 3 minutes post injection of isoproterenol.

干预措施: Isoproterenol Sensitivity Test (Other)

结局指标

主要结局

AUC (area under the plasma concentration-time curve) of carvedilol

时间窗: predose and 0.25, 0.5, 1, 2, 3, 4, 6, 12, 24h postdose

Cmax (Maximum plasma concentration) of carvedilol

时间窗: predose and 0.25, 0.5, 1, 2, 3, 4, 6, 12, 24h postdose

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jae Yong Chung

Associate Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验